The benefits of breastfeeding during COVID-19 crisis

While the current coronavirus pandemic continues to affect all people, families will still give birth and bring new life into the world. During the COVID-19 crisis, breastfeeding and the provision of human milk to infants is recommended by national and international organizations because it is effective against infectious diseases: It strengthens the immune system by directly transferring antibodies from the mother.

In an editorial in the Journal of Obstetric, Gynecologic & Neonatal Nursing, Diane Lynn Spatz, PhD, RN-BC, FAAN, Professor of Perinatal Nursing & The Helen M. Shearer Professor of Nutrition at the University of Pennsylvania School of Nursing (Penn Nursing), provides guidance regarding breastfeeding and COVID-19 and reaffirms why it is of paramount importance to promote and protect the use of human milk and breastfeeding.

While it is unknown if COVID-19-positive mothers can transmit the virus through milk, in limited studies the virus has not been detected in human milk. We should use this pandemic as a way to increase visibility of the critical role of human milk and breastfeeding for all families at all times and educate the public about the importance of the use of human milk and breastfeeding as lifesaving medical interventions."

Diane Lynn Spatz, Ph.D., RN-BC, FAAN, Professor of Perinatal Nursing & The Helen M. Shearer Professor of Nutrition at the University of Pennsylvania School of Nursing

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients